Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis
NCT06007508
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
8
Enrollment
OTHER
Sponsor class
Stopped
Study intervention was adopted as standard of care.
Conditions
DKA
Interventions
DRUG:
Insulin Glargine
Sponsor
HealthPartners Institute